DUBLIN, IRELAND and WASHINGTON, DC--(Marketwired - Oct 7, 2013) - neoSurgical, an international medical devices company focused on advancing safer and simpler solutions for Laparoscopic and Minimally Invasive Surgery (MIS), invites you to visit them at booth 1348 from October 6-10 at The 2013 Clinical Congress of the American College of Surgeons in Washington, DC. At their booth, neoSurgical will be discussing the current "standard of care" for port closures in addition to a hands-on demonstration of their recently unveiled product neoClose, an innovative new FDA-approved device designed to overcome the challenges of quickly, simply and effectively closing any port or access site in the abdominal wall following keyhole surgery.
Approximately 3 million laparoscopic surgeries are performed each year in the US and more than 5 million worldwide. Traditional port closure methods are especially difficult and very time consuming for patients with thick abdominal walls. Ineffective closure of intra-abdominal defects increases the patient's risk of herniation at the closure site. The complication rates can be as high at 6.3% due to obesity.
With millions of laparoscopic surgeries performed every year, the market size is more than $400M in the US alone. The multi-port closure market is expected to continue to grow as more surgeons are trained and innovative technologies improve surgical outcome. The neoClose device will have a competitive advantage due to the self-closing suture features lacking in other devices.
"There is a latent need for a consistent method for port closure following laparoscopic surgery," said Barry Russell, neoSurgical Founder and CEO. "There is continuing need for safer, simpler and a more consistent device based method for port closure following laparoscopic surgery and that was our aim with the invention of neoClose."
neoSurgical is an global medical device company focused on providing technical innovation to the surgical devices industry, particularly surgeons conducting laparoscopic and minimally invasive surgery (MIS). neoSurgical leverages its in-depth expertise in interpreting surgeons' needs that results in an engineering response to deliver compliant devices that make surgery safer, simpler and superior for both surgeons and patients. The company's European headquarters are in Dublin with U.S. headquarters in Chicago. More information about neoSurgical can be found at: www.neosurgical.com.